Biomorphological and related technical aspects affecting phage activity for inhaled application

S. Wienhold (Berlin, Germany), M. Brack (Berlin, Germany), W. Groenewald (Berlin, Germany), G. Nouailles (Berlin, Germany), I. Korf (Braunschweig, Germany), M. Rohde (Braunschweig, Germany), C. Seitz (Braunschweig, Germany), A. Dannheim (Braunschweig, Germany), S. Wienecke (Braunschweig, Germany), H. Ziehr (Braunschweig, Germany), C. Rohde (Braunschweig, Germany), M. Witzenrath (Berlin, Germany)

Source: Virtual Congress 2020 – Translational science in respiratory infections
Session: Translational science in respiratory infections
Session type: E-poster session
Number: 2326
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Wienhold (Berlin, Germany), M. Brack (Berlin, Germany), W. Groenewald (Berlin, Germany), G. Nouailles (Berlin, Germany), I. Korf (Braunschweig, Germany), M. Rohde (Braunschweig, Germany), C. Seitz (Braunschweig, Germany), A. Dannheim (Braunschweig, Germany), S. Wienecke (Braunschweig, Germany), H. Ziehr (Braunschweig, Germany), C. Rohde (Braunschweig, Germany), M. Witzenrath (Berlin, Germany). Biomorphological and related technical aspects affecting phage activity for inhaled application. 2326

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Technical aspects of physical activity monitoring
Source: International Congress 2015 – PG13 Monitoring physical activity
Year: 2015




When biology meets behaviour: can medication adherence mask the contribution of pharmacogenetic effects in asthma?
Source: Eur Respir J, 58 (3) 2100304; 10.1183/13993003.00304-2021
Year: 2021



SABINA: global programme to evaluate prescriptions and clinical outcomes related to short-acting ß2-agonist use in asthma
Source: Eur Respir J, 55 (2) 1901858; 10.1183/13993003.01858-2019
Year: 2020



Is the clinical application of specific airway resistance in young children limited by inter-centre differences? Reported on behalf of the asthma UK ‘growing lungs‘ initiative
Source: Annual Congress 2009 - Paediatric lung function, imaging and methodology in health and disease
Year: 2009


Usefulness of a new JACS questionnaire in assessing the influence of inhalation guidance on asthma control level; comparison of 4 different devices of ICS/LABA
Source: International Congress 2018 – Determinants and monitoring of asthma control
Year: 2018




The role of inhaled antibiotics in bronchial infection
Source: Eur Respir Monogr 2013; 60: 120-126
Year: 2013


Optimal adherence with inhaled corticosteroids is related to better health status
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015


Minimising the environmental impact of inhaled therapies: problems with policy on low carbon inhalers
Source: Eur Respir J, 55 (2) 2000048; 10.1183/13993003.00048-2020
Year: 2020



Minimising the environmental impact of inhaled therapies: problems with policy on low carbon inhalers
Source: Eur Respir J, 55 (5) 2001122; 10.1183/13993003.01122-2020
Year: 2020



Evaluating the effects of asthma therapy on childhood growth: principles of study design
Source: Eur Respir J 2002; 19: 1167-1178
Year: 2002



Comparitive efficiency of different approaches to basic therapy of bronchial asthma of moderate form
Source: Eur Respir J 2006; 28: Suppl. 50, 441s
Year: 2006

The influence of genetic and phenotypic factors over the ability to perform different physical exercises in a short programme of pulmonary rehabilitation
Source: Annual Congress 2009 - Are outcome measures useful to predict success in rehabilitation and the care of patients with chronic respiratory disease
Year: 2009


Is there evidence showing that real-life aspects (comorbid conditions, inhaler technique, and lifetstyle factors) influence asthma management?
Source: International Congress 2014 – The evolving role of real-life research in respiratory medicine
Year: 2014



Expanding role of aerosols: systemic drug delivery, gene therapy and vaccination
Source: Annual Congress 2007 - ISAM - Expanding role of aerosols: systemic drug delivery, gene therapy and vaccination
Year: 2007

Change of inhalation device: impact on asthma control and compliance in general practice. SYSTER survey
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases II
Year: 2008


Knowledge and skills for inhaled drugs before and after a rehabilitation program in COPD: a real life study
Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)?
Year: 2018

Evaluating the effects of asthma therapy on childhood growth: what can be learnt from the published literature?
Source: Eur Respir J 2002; 19: 1179-1193
Year: 2002



A critical evaluation of the relevance of different asthma phenotypes for clinical practice
Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium
Year: 2008


The challenge of increasing physical activity in the presence of asthma: a qualitative study of teachers‘ experiences and views
Source: Annual Congress 2009 - Quality of treatment in primary respiratory care
Year: 2009


Daily pattern of ß2-agonists: understanding real-life use of rescue medication
Source: International Congress 2017 – Asthma management
Year: 2017